PANCREATIC CANCER RESEARCH FUND — grant history

Registered charity 1155322 · filings on the Charity Commission register · its own accounts analysis · funder finder · deadlines · watch this funder · check a grantee list

Latest income
£1.5m
Grants listed (FY2025)
1
Listed grants total
£121k
Accounts grants total
£703k

listed grants do not fully reconcile with the accounts total — list may be partialextracted from its FY2025 accounts

What changed: FY2024 → FY2025

Grantees that appear, disappear or move by 50%+ between the two most recent filings that have counted grants (unverified reads are left out, so a filing whose grants are all unverified is skipped). A grantee “dropped” may simply have received a multi-year grant earlier.

ChangeGranteeFY2024FY2025
newQueen Mary University of London—£121k
not listedProfessor John Marshall, Queen Mary University of London£98k—

Grants made, per its accounts filings

Download this grant history as CSV (open data, provenance and licence noted in the file).

RecipientYearAmountPurpose
Queen Mary University of LondonFY2025£121kOne-year cost extension for the project ‘The integrin αvβ6 drives PDAC metastasis: mechanisms and therapeutic insights’
Professor John Marshall, Queen Mary University of LondonFY2024£98kOne-year cost extension for the project ‘The integrin avB6 drives PDAC metastasis: mechanisms and therapeutic insights’
PCRF Tissue BankFY2023£364kcontinued support and development of the PCRF Tissue Bank
Earlier granteesFY2023£182kAdditional grant payments (continuing payments to earlier grantees)
Cambridge UniversityFY2022£269kAdditional grant payments
Imperial College LondonFY2022£220kPersonalised therapy for pancreatic adenocarcinoma without toxicity through protease-sensitive masking and tumour targeting interleukin-12
Queen Mary University LondonFY2022£220kAnti-Histamines as Novel Therapeutics in Pancreatic Cancer
Barts Cancer Institute, Queen Mary University, LondonFY2022£220kAdditional grant payments
Oxford UniversityFY2022£220kAdditional grant payments
Cardiff University School of MedecineFY2022£219kEstablishing "organoid hospitals" as preclinical models to evaluate precision virotherapies
London School of Hygiene and Tropical MedecineFY2022£219kAdditional grant payments
University College LondonFY2022£219kCharacterising immune surveillance and dysfunction in early stage pancreatic cancer
University of LiverpoolFY2022£216kDefining the molecular mechanisms by which MIF impacts liver metastasis in pancreatic cancer and exploring its therapeutic application
Cambridge UniversityFY2022£210kAdditional grant payments
Barts Cancer Institute, Queen Mary University, LondonFY2022£65kAdditional grant payments
Barts Cancer Institute, Queen Mary University, LondonFY2021£220kThe integrin avb6 drives PDAC metastasis: mechanisms and therapeutic insights (Marshall, John)
Barts Cancer Institute, Queen Mary University, LondonFY2021£220kDevelopment of an enhanced oncolytic Vaccinia virus-based therapeutic regime that simultaneously targets multiple elements of the tumour promoting microenvironment in pancreatic cancer (Wang, Yaohe)
Cambridge UniversityFY2021£220kDesigning new strategies to target the tumour-promoting roles of pancreatic cancer fibroblasts (Biffi, Giulia)
London School of Hygiene and Tropical MedecineFY2021£219kA risk score for pancreatic cancer diagnosis using machine learning techniques applied to linked routine data: full case-control study and economic evaluation (Woods, Laura)
Cambridge UniversityFY2021£210kInvestigating subtype-specific therapeutic targets in the FOXA1 interactome of PDAC (Carroll, Jason)
Barts Cancer Institute, Queen Mary University, LondonFY2021£201kRetinoic acid regulation of pancreatic stellate cell phenotype (Kocher, Hemant)
Oxford UniversityFY2021£65kTargeting immunotherapy to the pancreatic tumour microenvironment using oncolytic viruses to direct T cell cytotoxicity to stress-induced ligands (Seymour, Len)

About this data

This grant list is extracted by automated reading of the grant-maker’s own accounts PDFs as filed with the Charity Commission, and cross-checked against the accounts’ stated grant totals (listed sum 120921 vs reference 703418 (82.8% diff; ref=stated)). Recipients are linked to register entries only on an exact charity-number or unambiguous exact-name match. If you represent this funder or a recipient and want a correction, email [email protected].